skip to content
Cytotoxic Drugs and the Granulopoietic System Preview this item
ClosePreview this item
Checking...

Cytotoxic Drugs and the Granulopoietic System

Author: Hans-Peter Lohrmann; Wolfgang Schreml
Publisher: Berlin, Heidelberg : Springer Berlin Heidelberg, 1982.
Series: Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, 81; Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, 81.
Edition/Format:   eBook : Document : EnglishView all editions and formats
Summary:
Since cytotoxic drugs were first developed, their damaging effects on bone marrow have attracted considerable interest. We now know that the bone marrow is an organ with rapid cell renewal in which maintenance of the steady-state depends on a high rate of cell production, and that the bone marrow toxicity of cytotoxic agents can be explained by the perturbation of such steady-state conditions. Experimental  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy online

Links to this item

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Electronic books
Additional Physical Format: Print version:
Material Type: Document, Internet resource
Document Type: Internet Resource, Computer File
All Authors / Contributors: Hans-Peter Lohrmann; Wolfgang Schreml
ISBN: 9783642816901 3642816908 9783642816925 3642816924
OCLC Number: 858930925
Description: 1 online resource.
Contents: 1 Introduction --
2 Structure and Physiology of the Granulopoietic System --
3 Some Methods Used to Study the Granulopoietic System --
3.1 Pluripotent Stem Cell Assay (CFU-S Assay) --
3.2 Stem Cells Committed to Granulopoiesis (Granulopoietic Prognitor Cells) (CFU-C) --
3.3 Agar-Diffusion-Chamber Progenitor Cells --
3.4 Sensitivity Studies --
3.5 Recovery Studies --
3.6 Proliferative Activity of Stem Cells --
3.7 'Rapidly Proliferating' Stem Cells --
3.8 Functional Bone Marrow Granulocyte Reserve --
3.9 Bone Marrow Cellularity --
4 Effect of Individual Cytotoxic Agents Upon the Granulopoietic System --
4.1 Nitrogen Mustards --
4.2 Chlorambucil --
4.3 Aminochlorambucil --
4.4 Cyclophosphamide --
4.5 Melphalan (L-Phenylalanine Mustard) --
4.6 Busulfan --
4.7 Dimethyl Myleran (DMM) --
4.8 Methotrexate (MTX) --
4.9 5-Fluorouracil (5-FU) --
4.10 Cytosine Arabinoside (Ara-C) --
4.11 6-Mercaptopurine (6-MP) --
4.12 6-Thioguanine(6-TG) --
4.13 Vinblastine (VLB) --
4.14 Vincristine (VCR) --
4.15 Actinomycin D (Act-D) --
4.16 Anthracyclines --
4.17 Bleomycin --
4.18 Hydroxyurea (HU) --
4.19 DTIC (5-[3,3-dimethyl-l-triazeno]-imidazole-4-carboxamide) --
4.20 Nitrosoureas --
4.21 cis-Diamminedichloroplatinum(DDP) --
5 Granulopoietic Toxicity of Cytotoxic Agents: Pathogenesis, Pathophysiology, Methods of Modulation, and Clinical Aspects --
5.1 General Discussion of Cytotoxic Drug Effects on the Granulopoietic System --
5.2 Modulation of the Granulopoietic Toxicity of Cytotoxic Agents by Bacterial Products or 'Immunostimulants' --
5.3 Effect of Lithium Upon the Granulopoietic System --
5.4 Prediction of Hematopoietic Toxicity of Cytotoxic Chemotherapy in Humans --
5.5 Problem of Irreversible Bone Marrow Damage After Cytotoxic Drug Exposure --
6 References --
7 Subject Index.
Series Title: Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, 81; Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, 81.
Responsibility: by Hans-Peter Lohrmann, Wolfgang Schreml.

Abstract:

Since cytotoxic drugs were first developed, their damaging effects on bone marrow have attracted considerable interest. We now know that the bone marrow is an organ with rapid cell renewal in which maintenance of the steady-state depends on a high rate of cell production, and that the bone marrow toxicity of cytotoxic agents can be explained by the perturbation of such steady-state conditions. Experimental researchers have analysed in detail the effects of cytotoxic agents upon defined hematopoietic cell populations to define the mechanism of action and the location within the cell cycle at which cytotoxic drugs exert their cytocidal action. From such studies, a classification of cytotoxic agents according to their action upon cells during different phases of the cell cycle has been proposed [80-82]. Others have used the acute perturbation of the hematopoietic systems, caused by application of single high doses of cytotoxic agents, to analyse the patterns of depletion and reconstitution of the various hematopoietic compartments in an effort to shed light on the regulatory mechanisms that are responsible for the delicately balanced cell production of the hematopoietic cell renewal systems. A great deal of information on the structure of the hematopoietic systems has come from such studies, and kinetic parameters of these systems have been defined. To clinicians, the hematopoietic toxicity of antineoplastic agents has been an undesired though unavoidable side effect of almost all cytotoxic drugs introduced into clinical practice.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.

Similar Items

Related Subjects:(2)

Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/858930925> # Cytotoxic Drugs and the Granulopoietic System
    a schema:CreativeWork, schema:MediaObject, schema:Book ;
    library:oclcnum "858930925" ;
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/gw> ;
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/29753457#Place/berlin_heidelberg> ; # Berlin, Heidelberg
    schema:about <http://id.worldcat.org/fast/1045739> ; # Oncology
    schema:about <http://id.worldcat.org/fast/1014893> ; # Medicine
    schema:about <http://dewey.info/class/616.994/e23/> ;
    schema:bookFormat schema:EBook ;
    schema:contributor <http://experiment.worldcat.org/entity/work/data/29753457#Person/schreml_wolfgang> ; # Wolfgang Schreml
    schema:creator <http://experiment.worldcat.org/entity/work/data/29753457#Person/lohrmann_hans_peter> ; # Hans-Peter Lohrmann
    schema:datePublished "1982" ;
    schema:description "1 Introduction -- 2 Structure and Physiology of the Granulopoietic System -- 3 Some Methods Used to Study the Granulopoietic System -- 3.1 Pluripotent Stem Cell Assay (CFU-S Assay) -- 3.2 Stem Cells Committed to Granulopoiesis (Granulopoietic Prognitor Cells) (CFU-C) -- 3.3 Agar-Diffusion-Chamber Progenitor Cells -- 3.4 Sensitivity Studies -- 3.5 Recovery Studies -- 3.6 Proliferative Activity of Stem Cells -- 3.7 'Rapidly Proliferating' Stem Cells -- 3.8 Functional Bone Marrow Granulocyte Reserve -- 3.9 Bone Marrow Cellularity -- 4 Effect of Individual Cytotoxic Agents Upon the Granulopoietic System -- 4.1 Nitrogen Mustards -- 4.2 Chlorambucil -- 4.3 Aminochlorambucil -- 4.4 Cyclophosphamide -- 4.5 Melphalan (L-Phenylalanine Mustard) -- 4.6 Busulfan -- 4.7 Dimethyl Myleran (DMM) -- 4.8 Methotrexate (MTX) -- 4.9 5-Fluorouracil (5-FU) -- 4.10 Cytosine Arabinoside (Ara-C) -- 4.11 6-Mercaptopurine (6-MP) -- 4.12 6-Thioguanine(6-TG) -- 4.13 Vinblastine (VLB) -- 4.14 Vincristine (VCR) -- 4.15 Actinomycin D (Act-D) -- 4.16 Anthracyclines -- 4.17 Bleomycin -- 4.18 Hydroxyurea (HU) -- 4.19 DTIC (5-[3,3-dimethyl-l-triazeno]-imidazole-4-carboxamide) -- 4.20 Nitrosoureas -- 4.21 cis-Diamminedichloroplatinum(DDP) -- 5 Granulopoietic Toxicity of Cytotoxic Agents: Pathogenesis, Pathophysiology, Methods of Modulation, and Clinical Aspects -- 5.1 General Discussion of Cytotoxic Drug Effects on the Granulopoietic System -- 5.2 Modulation of the Granulopoietic Toxicity of Cytotoxic Agents by Bacterial Products or 'Immunostimulants' -- 5.3 Effect of Lithium Upon the Granulopoietic System -- 5.4 Prediction of Hematopoietic Toxicity of Cytotoxic Chemotherapy in Humans -- 5.5 Problem of Irreversible Bone Marrow Damage After Cytotoxic Drug Exposure -- 6 References -- 7 Subject Index."@en ;
    schema:description "Since cytotoxic drugs were first developed, their damaging effects on bone marrow have attracted considerable interest. We now know that the bone marrow is an organ with rapid cell renewal in which maintenance of the steady-state depends on a high rate of cell production, and that the bone marrow toxicity of cytotoxic agents can be explained by the perturbation of such steady-state conditions. Experimental researchers have analysed in detail the effects of cytotoxic agents upon defined hematopoietic cell populations to define the mechanism of action and the location within the cell cycle at which cytotoxic drugs exert their cytocidal action. From such studies, a classification of cytotoxic agents according to their action upon cells during different phases of the cell cycle has been proposed [80-82]. Others have used the acute perturbation of the hematopoietic systems, caused by application of single high doses of cytotoxic agents, to analyse the patterns of depletion and reconstitution of the various hematopoietic compartments in an effort to shed light on the regulatory mechanisms that are responsible for the delicately balanced cell production of the hematopoietic cell renewal systems. A great deal of information on the structure of the hematopoietic systems has come from such studies, and kinetic parameters of these systems have been defined. To clinicians, the hematopoietic toxicity of antineoplastic agents has been an undesired though unavoidable side effect of almost all cytotoxic drugs introduced into clinical practice."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/29753457> ;
    schema:genre "Electronic books"@en ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://worldcat.org/issn/0080-0015> ; # Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer ;
    schema:isSimilarTo <http://worldcat.org/entity/work/data/29753457#CreativeWork/> ;
    schema:name "Cytotoxic Drugs and the Granulopoietic System"@en ;
    schema:productID "858930925" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/858930925#PublicationEvent/berlin_heidelberg_springer_berlin_heidelberg_1982> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/29753457#Agent/springer_berlin_heidelberg> ; # Springer Berlin Heidelberg
    schema:url <http://link.springer.com/10.1007/978-3-642-81690-1> ;
    schema:url <https://link.springer.com/openurl?genre=book&isbn=978-3-540-10962-4> ;
    schema:url <http://public.eblib.com/choice/publicfullrecord.aspx?p=3095586> ;
    schema:url <http://dx.doi.org/10.1007/978-3-642-81690-1> ;
    schema:workExample <http://worldcat.org/isbn/9783642816925> ;
    schema:workExample <http://worldcat.org/isbn/9783642816901> ;
    schema:workExample <http://dx.doi.org/10.1007/978-3-642-81690-1> ;
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/858930925> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/29753457#Agent/springer_berlin_heidelberg> # Springer Berlin Heidelberg
    a bgn:Agent ;
    schema:name "Springer Berlin Heidelberg" ;
    .

<http://experiment.worldcat.org/entity/work/data/29753457#Person/lohrmann_hans_peter> # Hans-Peter Lohrmann
    a schema:Person ;
    schema:familyName "Lohrmann" ;
    schema:givenName "Hans-Peter" ;
    schema:name "Hans-Peter Lohrmann" ;
    .

<http://experiment.worldcat.org/entity/work/data/29753457#Person/schreml_wolfgang> # Wolfgang Schreml
    a schema:Person ;
    schema:familyName "Schreml" ;
    schema:givenName "Wolfgang" ;
    schema:name "Wolfgang Schreml" ;
    .

<http://experiment.worldcat.org/entity/work/data/29753457#Place/berlin_heidelberg> # Berlin, Heidelberg
    a schema:Place ;
    schema:name "Berlin, Heidelberg" ;
    .

<http://id.worldcat.org/fast/1014893> # Medicine
    a schema:Intangible ;
    schema:name "Medicine"@en ;
    .

<http://id.worldcat.org/fast/1045739> # Oncology
    a schema:Intangible ;
    schema:name "Oncology"@en ;
    .

<http://link.springer.com/10.1007/978-3-642-81690-1>
    rdfs:comment "from Springer" ;
    rdfs:comment "(Unlimited Concurrent Users)" ;
    .

<http://worldcat.org/entity/work/data/29753457#CreativeWork/>
    a schema:CreativeWork ;
    schema:description "Print version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/858930925> ; # Cytotoxic Drugs and the Granulopoietic System
    .

<http://worldcat.org/isbn/9783642816901>
    a schema:ProductModel ;
    schema:isbn "3642816908" ;
    schema:isbn "9783642816901" ;
    .

<http://worldcat.org/isbn/9783642816925>
    a schema:ProductModel ;
    schema:isbn "3642816924" ;
    schema:isbn "9783642816925" ;
    .

<http://worldcat.org/issn/0080-0015> # Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer ;
    a bgn:PublicationSeries ;
    schema:hasPart <http://www.worldcat.org/oclc/858930925> ; # Cytotoxic Drugs and the Granulopoietic System
    schema:issn "0080-0015" ;
    schema:name "Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer ;" ;
    schema:name "Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer," ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.